<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Beta Bionics, Inc. Common Stock — News on 6ix</title>
    <link>https://6ix.com/company/beta-bionics-inc-common-stock</link>
    <description>Latest news and press releases for Beta Bionics, Inc. Common Stock on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 21 Apr 2026 20:03:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/beta-bionics-inc-common-stock" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68354b4a78dffbe2df0e5089.webp</url>
      <title>Beta Bionics, Inc. Common Stock</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock</link>
    </image>
    <item>
      <title>Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-first-quarter-2026-financial-results-and-raises-full-year-2026-guidance</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-first-quarter-2026-financial-results-and-raises-full-year-2026-guidance</guid>
      <pubDate>Tue, 21 Apr 2026 20:03:00 GMT</pubDate>
      <description>IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended March 31, 2026 and raised its full year guidance for the year ending December 31, 2026. First Quarter 2026 Financial Highlights &amp; Key Metrics Net sales of $27.6 million, up 57% compared to $17.6 million in the first quarter of 2025. Durable Medical Equipment (DME) channel</description>
    </item>
    <item>
      <title>Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-introduces-bionic-insightstm-in-bionic-reports-transforming-how-clinicians-understand-and-optimize-diabetes-care</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-introduces-bionic-insightstm-in-bionic-reports-transforming-how-clinicians-understand-and-optimize-diabetes-care</guid>
      <pubDate>Tue, 31 Mar 2026 04:00:00 GMT</pubDate>
      <description>Advanced report intelligence delivers actionable guidance to improve outcomes for people using the iLet Bionic Pancreas IRVINE, Calif., March 31, 2026 (GLOBE</description>
    </item>
    <item>
      <title>Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-to-announce-first-quarter-2026-financial-results-on-april-21-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-to-announce-first-quarter-2026-financial-results-on-april-21-2026</guid>
      <pubDate>Mon, 30 Mar 2026 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-to-present-at-the-td-cowen-46th-annual-health-care-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-to-present-at-the-td-cowen-46th-annual-health-care-conference</guid>
      <pubDate>Thu, 19 Feb 2026 21:05:00 GMT</pubDate>
      <description>IRVINE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at TD Cowen’s 46th Annual Health Care Conference on Wednesday, March 4, 2026 at 10:30 am Eastern Time (7:30 am Pacific Time). A live audio webcast of the presentation will be available on the Company’s website in the “Investors—Events &amp; Presentations” section at https://investors.betabio</description>
    </item>
    <item>
      <title>Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-fourth-quarter-210500451</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-fourth-quarter-210500451</guid>
      <pubDate>Tue, 17 Feb 2026 21:05:00 GMT</pubDate>
      <description>IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter and year ended December 31, 2025 and introduced its annual guidance for the year ending December 31, 2026. Fourth Quarter 2025 Financial Highlights &amp; Key Metrics Net sales of $32.1 million, up 57% compared to $20.4 million in the fourth quarter of 2024. Durable Medical Equipment</description>
    </item>
    <item>
      <title>Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announce-fourth-quarter-and-full-year-2025-financial-results-february-17</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announce-fourth-quarter-and-full-year-2025-financial-results-february-17</guid>
      <pubDate>Thu, 15 Jan 2026 05:00:00 GMT</pubDate>
      <description>IRVINE, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-preliminary-unaudited-fourth-quarter-2025-topline-financial</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-preliminary-unaudited-fourth-quarter-2025-topline-financial</guid>
      <pubDate>Thu, 08 Jan 2026 05:00:00 GMT</pubDate>
      <description>IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-pre-announce-topline-fourth-quarter-2025-financial-results-week-january</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-pre-announce-topline-fourth-quarter-2025-financial-results-week-january</guid>
      <pubDate>Mon, 08 Dec 2025 05:00:00 GMT</pubDate>
      <description>IRVINE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced</description>
    </item>
    <item>
      <title>Beta Bionics Announces Participation at Upcoming Investor Conferences</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-participation-upcoming-investor-conferences-2025-11-03</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-participation-upcoming-investor-conferences-2025-11-03</guid>
      <pubDate>Mon, 03 Nov 2025 05:00:00 GMT</pubDate>
      <description>IRVINE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-reports-third-quarter-2025-financial-results-and-raises-full-year-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-reports-third-quarter-2025-financial-results-and-raises-full-year-2025</guid>
      <pubDate>Tue, 28 Oct 2025 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announce-third-quarter-2025-financial-results-october-28-2025-2025-10-09</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announce-third-quarter-2025-financial-results-october-28-2025-2025-10-09</guid>
      <pubDate>Thu, 09 Oct 2025 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-reports-second-quarter-2025-financial-results-and-raises-full-year-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-reports-second-quarter-2025-financial-results-and-raises-full-year-2025</guid>
      <pubDate>Tue, 29 Jul 2025 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announce-second-quarter-2025-financial-results-july-29-2025-2025-07-02</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announce-second-quarter-2025-financial-results-july-29-2025-2025-07-02</guid>
      <pubDate>Wed, 02 Jul 2025 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-agreement-abbott-integrate-ilet-bionic-pancreas-abbotts-future</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-agreement-abbott-integrate-ilet-bionic-pancreas-abbotts-future</guid>
      <pubDate>Thu, 19 Jun 2025 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions,</description>
    </item>
    <item>
      <title>Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-reports-first-quarter-2025-financial-results-and-raises-annual-guidance</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-reports-first-quarter-2025-financial-results-and-raises-annual-guidance</guid>
      <pubDate>Tue, 06 May 2025 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics to Present at the Bank of America Securities Health Care Conference</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-present-bank-america-securities-health-care-conference-2025-05-01</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-present-bank-america-securities-health-care-conference-2025-05-01</guid>
      <pubDate>Thu, 01 May 2025 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announce-first-quarter-2025-financial-results-may-6-2025-2025-04-16</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announce-first-quarter-2025-financial-results-may-6-2025-2025-04-16</guid>
      <pubDate>Wed, 16 Apr 2025 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics to Host Investor Event on June 22, 2025</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-host-investor-event-june-22-2025-2025-04-09</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-host-investor-event-june-22-2025-2025-04-09</guid>
      <pubDate>Wed, 09 Apr 2025 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced</description>
    </item>
    <item>
      <title>Beta Bionics Announces Board Appointment of Gerard Michel</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-board-appointment-gerard-michel-2025-03-27</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-board-appointment-gerard-michel-2025-03-27</guid>
      <pubDate>Thu, 27 Mar 2025 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
    <item>
      <title>Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025</title>
      <link>https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-fourth-quarter-and-full-year-2024-financial-results-and</link>
      <guid isPermaLink="true">https://6ix.com/company/beta-bionics-inc-common-stock/news/beta-bionics-announces-fourth-quarter-and-full-year-2024-financial-results-and</guid>
      <pubDate>Tue, 25 Mar 2025 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management</description>
    </item>
  </channel>
</rss>